Literature DB >> 2965754

Dopamine D-1 receptor agonist stimulation of prolactin secretion in man.

G Fabbrini1, A Braun, M M Mouradian, C A Tamminga, T N Chase.   

Abstract

SKF 38393, a selective D-1 dopamine receptor agonist, elevated plasma prolactin levels in eight patients with various neurological disorders. Growth hormone concentrations were unaffected by SKF 38393 administration. The results suggest that D-1 receptors may be involved in the regulation of prolactin secretion.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2965754     DOI： 10.1007/bf01245709

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  21 in total

Review 1.  Role of brain monoamines and histamine in regulation of anterior pituitary secretion.

Authors:  R I Weiner; W F Ganong
Journal:  Physiol Rev       Date:  1978-10       Impact factor: 37.312

Review 2.  Multiple receptors for dopamine.

Authors:  J W Kebabian; D B Calne
Journal:  Nature       Date:  1979-01-11       Impact factor: 49.962

3.  Physiological concentrations of dopamine decrease adenosine 3',5'-monophosphate levels in cultured rat anterior pituitary cells and enriched populations of lactotrophs: evidence for a causal relationship to inhibition of prolactin release.

Authors:  L Swennen; C Denef
Journal:  Endocrinology       Date:  1982-08       Impact factor: 4.736

4.  D2- but not D3-dopamine receptors detected in the anterior pituitary.

Authors:  M Titeler; G R Van Loon; P Seeman; G M Brown
Journal:  Eur J Pharmacol       Date:  1981-04-24       Impact factor: 4.432

5.  Quantitative autoradiographic localization of the D1 and D2 subtypes of dopamine receptors in rat brain.

Authors:  S J Boyson; P McGonigle; P B Molinoff
Journal:  J Neurosci       Date:  1986-11       Impact factor: 6.167

6.  SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems.

Authors:  L C Iorio; A Barnett; F H Leitz; V P Houser; C A Korduba
Journal:  J Pharmacol Exp Ther       Date:  1983-08       Impact factor: 4.030

7.  Dopaminergic stimulation of prolactin release.

Authors:  C Denef; D Manet; R Dewals
Journal:  Nature       Date:  1980-05-22       Impact factor: 49.962

8.  The central effects of a novel dopamine agonist.

Authors:  P E Setler; H M Sarau; C L Zirkle; H L Saunders
Journal:  Eur J Pharmacol       Date:  1978-08-15       Impact factor: 4.432

9.  Dopaminergic mechanisms and motor function: characterization of D-1 and D-2 dopamine receptor interactions.

Authors:  P Barone; T A Davis; A R Braun; T N Chase
Journal:  Eur J Pharmacol       Date:  1986-04-09       Impact factor: 4.432

10.  Dopamine in hypophysial portal plasma of the rat during the estrous cycle and throughout pregnancy.

Authors:  N Ben-Jonathan; C Oliver; H J Weiner; R S Mical; J C Porter
Journal:  Endocrinology       Date:  1977-02       Impact factor: 4.736
View more
  4 in total

Review 1.  Pharmacology of signaling induced by dopamine D(1)-like receptor activation.

Authors:  Ashiwel S Undieh
Journal:  Pharmacol Ther       Date:  2010-06-12       Impact factor: 12.310

2.  Evidence for prolonged recovery of dopaminergic transmission after detoxification in alcoholics with poor treatment outcome.

Authors:  A Heinz; B Lichtenberg-Kraag; S S Baum; K Graf; F Kruger; M Dettling; H Rommelspacher
Journal:  J Neural Transm Gen Sect       Date:  1995

3.  Neuroendocrinological and neuropsychological correlates of dopaminergic function in nicotine dependence.

Authors:  Michael N Smolka; Henning Budde; Anne C Karow; Lutz G Schmidt
Journal:  Psychopharmacology (Berl)       Date:  2004-09       Impact factor: 4.530

4.  Prolactin and fMRI response to SKF38393 in the baboon.

Authors:  Brad Miller; Lauren A Marks; Jonathan M Koller; Blake J Newman; G Larry Bretthorst; Kevin J Black
Journal:  PeerJ       Date:  2013-10-29       Impact factor: 2.984
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.